Chronic lymphocytic leukemia

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.

A new drug is giving new hope to sufferers of this form of leukemia. Sen Zhuang, M.D., Ph.D., explains the science behind it—and why he thinks cancer researchers have a lot in common with Steve Jobs.

In just three years, HealtheVoices has had a big impact on the online health advocate and patient blogger community. Here’s how it came to be—and where it’s headed.